Gen-Probe to Webcast Two Upcoming Investor Presentations
March 04 2010 - 7:50PM
PR Newswire (US)
SAN DIEGO, March 4 /PRNewswire-FirstCall/ -- Gen-Probe Incorporated
announced today that the Company will present at the Cowen and
Company 30th Annual Healthcare Conference in Boston on March 9 at
approximately 1:30 p.m. Eastern time, and at the Barclays Capital
2010 Global Healthcare Conference in Miami on March 23 at
approximately 11:15 a.m. Eastern time. The presentations are
scheduled to be webcast live and may be accessed through a link on
the investors section of Gen-Probe's website at
http://www.gen-probe.com/. The webcasts will be available for 30
days following the event. About Gen-Probe Gen-Probe Incorporated is
a global leader in the development, manufacture and marketing of
rapid, accurate and cost-effective molecular diagnostic products
and services that are used primarily to diagnose human diseases,
screen donated human blood, and ensure transplant compatibility.
Gen-Probe has approximately 27 years of NAT expertise, and received
the 2004 National Medal of Technology, America's highest honor for
technological innovation, for developing NAT assays for blood
screening. Gen-Probe is headquartered in San Diego and employs
approximately 1,300 people. For more information, go to
http://www.gen-probe.com/. Caution Regarding Forward-Looking
Statements Any statements in this press release about our
expectations, beliefs, plans, objectives, assumptions or future
events or performance are not historical facts and are
forward-looking statements. Forward-looking statements are not
guarantees of performance. They involve known and unknown risks,
uncertainties and assumptions that may cause actual results, levels
of activity, performance or achievements to differ materially from
those expressed or implied. For information about risks and
uncertainties we face and a discussion of our financial statements
and footnotes, see documents we have filed with the SEC, including
our most recent Form 10-Q, and all subsequent periodic filings made
with the SEC. We assume no obligation and expressly disclaim any
duty to update any forward-looking statement to reflect events or
circumstances after the date of this press release or to reflect
the occurrence of unanticipated events. Contact: -------- Paula
Izidoro Investor Relations 858-410-8904 DATASOURCE: Gen-Probe
Incorporated CONTACT: Paula Izidoro, Investor Relations of
Gen-Probe Incorporated,+1-858-410-8904 Web Site:
http://www.gen-probe.com/
Copyright
GoPro (NASDAQ:GPRO)
Historical Stock Chart
From Jun 2024 to Jul 2024
GoPro (NASDAQ:GPRO)
Historical Stock Chart
From Jul 2023 to Jul 2024